Oleanolic acid induces HCT116 colon cancer cell death through the p38/FOXO3a/Sirt6 pathway

Iva Potočnjak1, Lidija Šimić1, Iva Vukelić1

  • 1Department of Medical Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Rijeka, Croatia.

Insights

Oleanolic acid (OA) triggers apoptosis and mitophagy in colon cancer cells, inhibiting tumor growth. It also enhances the effectiveness of 5-fluorouracil (5-FU) chemotherapy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Oleanolic acid (OA), a natural compound, exhibits anticancer properties.
  • The role of forkhead box O3a (FOXO3a) in OA-induced autophagy and mitophagy in colon cancer remains to be elucidated.

Purpose of the Study:

  • To investigate the role of FOXO3a in OA-induced autophagy and mitophagy in the HCT116 colon cancer cell line.
  • To explore the underlying signaling pathways involved in OA's anticancer effects.

Main Methods:

  • Cell viability assays (IC50 determination).
  • Western blotting to assess apoptosis markers (cleaved caspase-3, PARP1) and autophagy/mitophagy markers (Beclin-1, ATG5, LC3B, p62, PINK1, TOMM20).
  • Immunofluorescence for LC3B colocalization.
  • Analysis of FOXO3a nuclear accumulation and p38 MAPK pathway.
  • In vivo studies using colon cancer xenograft mouse models.
  • Assessment of OA's effect on 5-fluorouracil (5-FU) chemosensitivity.

Main Results:

  • OA dose-dependently reduced HCT116 cell viability and induced apoptosis.
  • OA triggered autophagy and mitophagy, indicated by altered expression of key proteins and LC3B colocalization with mitochondrial markers.
  • OA induced nuclear accumulation of FOXO3a and upregulated p38.
  • Inhibition of p38 increased FOXO3a and Sirtuin 6 (Sirt6) expression.
  • OA suppressed tumor growth in vivo and enhanced 5-FU efficacy.

Conclusions:

  • OA induces apoptosis and prosurvival mitophagy in colon cancer cells via the p38/FOXO3a/Sirt6 signaling pathway.
  • OA demonstrates potential as an anticancer agent and a chemosensitizer for colon cancer treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K